Bitcoin’s market cap of around $1.4 trillion is a tiny fraction of global wealth, implying substantial room for growth through institutional, governmental, and asset-manager inflows.

Bitcoin emerges as the stronger long‑term crypto investment, underpinned by its fixed 21 million supply, robust network fundamentals, and a history of recovering from large drawdowns, with increasing institutional involvement and a high network hash rate supporting further upside.

Readers are cautioned to consider stock investments alongside crypto, noting Motley Fool Stock Advisor recommendations and the fact that Bitcoin was not among recent top stock picks, even as Fool remains positive on both Bitcoin and XRP overall.

Bitcoin’s fundamentals—scarce supply, widespread node presence, and a strong hash rate—are cited as foundations for long‑term upside as bigger players enter the space.

XRP is portrayed as attempting to disrupt cross‑border payments but is criticized for limited adoption and a use case that has not been rewarded by the market, reflected in notable price declines and ongoing volatility.

XRP is said to be failing to fulfill its stated cross‑border payments promise, with limited institutional use and continuing volatility, including declines in 2025 and into 2026.

XRP is framed largely as a speculative tool rather than a widely used payments solution, contrasting with Bitcoin’s broader asset‑utilitarian trajectory.

Bitcoin is depicted as the better crypto buy relative to XRP, with BTC down about 44% from its October 2025 peak as of March, while XRP sits roughly 63% below its January 2018 peak.

Bitcoin’s scarcity, rising institutional interest, and potential for large capital inflows are cited as reasons for a decade‑long holding strategy, despite macro factors that will influence prices.

Bitcoin remains the leading crypto asset with substantial upside potential for patient, long‑term holders, supported by the current market stance and signals of continued growth.

The piece ultimately argues that Bitcoin should be the superior addition to a balanced portfolio, urging patient investors to buy the dip and hold for a decade.